Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
BeiGene, Ltd. (BGNE)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
29 Feb 2024
Wang Julia Aijun
Chief Financial Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
397
$167.08
$66,330.76
SELL
31 Jul 2023
Lee Chan Henry
SVP, General Counsel, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
791
$216.26
$171,059.05
SELL
12 Jul 2023
Daniel Goldman
Congressman (House)
BeiGene, Ltd.
(BGNE)
N/A
N/A
N/A
$1,001 - $15,000
SELL
10 Jul 2023
Daniel Goldman
Congressman (House)
BeiGene, Ltd.
(BGNE)
N/A
N/A
N/A
$1,001 - $15,000
SELL
3 Jul 2023
Wang Julia Aijun
Chief Financial Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
472
$179.55
$84,747.37
SELL
26 Jun 2023
Wu Xiaobin
President, COO & GM China, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,495
$182.37
$272,635.70
SELL
26 Jun 2023
Wang Lai
Global Head of R&D, Officer
BeiGene, Ltd.
(BGNE)
5
-99%
1,108
$181.92
$201,567.33
SELL
23 Jun 2023
Sanders Corazon (Corsee) D.
Director
BeiGene, Ltd.
(BGNE)
478
-54%
578
$182.32
$105,381.42
SELL
23 Jun 2023
Wang Julia Aijun
Chief Financial Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
840
$182.85
$153,594.00
SELL
15 Jun 2023
Wang Lai
Global Head of R&D, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,325
$192.42
$254,955.45
SELL
13 Jun 2023
HHLR ADVISORS, LTD.
10% Owner
BeiGene, Ltd.
(BGNE)
142,888,240
-0%
1,198,128
$188.88
$226,306,340.00
SELL
8 Jun 2023
HHLR ADVISORS, LTD.
10% Owner
BeiGene, Ltd.
(BGNE)
145,055,180
-1%
2,956,689
$201.98
$597,183,900.00
SELL
7 Jun 2023
Wu Xiaobin
President, COO & GM China, Officer
BeiGene, Ltd.
(BGNE)
2,760
-54%
3,291
$224.73
$739,599.25
SELL
7 Jun 2023
Wang Lai
Global Head of R&D, Officer
BeiGene, Ltd.
(BGNE)
388
-54%
462
$224.74
$103,828.48
SELL
1 Mar 2023
Wang Julia Aijun
Chief Financial Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
343
$240.21
$82,391.89
SELL
12 Jan 2023
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
901
-84%
5,000
$260.52
$1,302,584.60
SELL
10 Jan 2023
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
5,918
-77%
20,391
$248.51
$5,067,449.00
SELL
9 Jan 2023
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
2,300
-68%
5,000
$251.36
$1,256,798.90
SELL
27 Dec 2022
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
91
-99%
9,609
$224.43
$2,156,571.80
SELL
13 Dec 2022
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
1,621
-65%
3,013
$211.33
$636,723.00
SELL
15 Nov 2022
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
23,600
-55%
29,928
$206.84
$6,190,333.50
SELL
15 Nov 2022
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
0
-100%
1,987
$210.14
$417,541.40
SELL
20 Sep 2022
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
7,740
-86%
50,000
$152.13
$7,606,556.00
SELL
1 Jul 2022
Wang Julia Aijun
Chief Financial Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
295
$158.50
$46,757.50
SELL
27 Jun 2022
Wang Lai
Global Head of R&D, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
458
$177.32
$81,214.72
SELL
17 Jun 2022
Wang Lai
Global Head of R&D, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,168
$145.35
$169,767.40
SELL
17 Jun 2022
Wu Xiaobin
President, COO & GM China, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,588
$142.63
$226,494.81
SELL
17 Jun 2022
Wang Julia Aijun
Chief Financial Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
161
$136.64
$21,998.93
SELL
6 Jun 2022
Wang Lai
Global Head of R&D, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
660
$142.00
$93,717.56
SELL
6 Jun 2022
Wu Xiaobin
President, COO & GM China, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
3,410
$141.99
$484,201.60
SELL
5 May 2022
Wu Xiaobin
President, COO & GM China, Officer
BeiGene, Ltd.
(BGNE)
5,925
-53%
6,725
$164.35
$1,105,275.80
SELL
14 Dec 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,200
-55%
1,500
$278.14
$417,211.00
SELL
30 Nov 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
519
-66%
1,049
$359.86
$377,492.70
SELL
17 Nov 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,300
-53%
1,500
$381.34
$572,003.40
SELL
8 Nov 2021
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
4,100
-52%
4,500
$350.04
$1,575,201.90
SELL
8 Nov 2021
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
4,200
-51%
4,500
$349.81
$1,574,148.00
SELL
8 Nov 2021
Wu Xiaobin
President, COO & GM China, Officer
BeiGene, Ltd.
(BGNE)
2,034
-83%
10,000
$358.27
$3,582,663.20
SELL
19 Oct 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,300
-53%
1,500
$372.78
$559,163.00
SELL
20 Sep 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
5,900
-50%
6,000
$397.96
$2,387,774.00
SELL
14 Sep 2021
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
1,736,904
-19%
411,838
$82.04
$33,788,320.00
SELL
13 Sep 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
8,682
-59%
12,901
$358.14
$4,620,389.50
BUY
10 Sep 2021
AMGEN INC
10% Owner
BeiGene, Ltd.
(BGNE)
18,943,802
+0%
165,529
$302.06
$49,999,936.00
SELL
31 Aug 2021
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
20,099
-93%
288,639
$109.77
$31,685,328.00
SELL
31 Aug 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,087
$318.88
$346,620.90
SELL
4 Aug 2021
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
4,217,173
-2%
125,309
$132.34
$16,583,634.00
SELL
3 Aug 2021
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
4,847,790
-1%
83,359
$182.37
$15,202,047.00
SELL
22 Jul 2021
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
5,434,657
-1%
69,216
$71.82
$4,971,360.50
SELL
20 Jul 2021
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
5,639,665
-1%
70,855
$152.13
$10,778,877.00
SELL
15 Jul 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
18,621
-53%
21,000
$332.42
$6,980,771.00
SELL
7 Jul 2021
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
6,085,580
-1%
67,481
$94.83
$6,399,303.50
SELL
6 Jul 2021
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
6,343,333
-1%
123,821
$117.22
$14,514,638.00
SELL
6 Jul 2021
Wu Xiaobin
President, COO & GM China, Officer
BeiGene, Ltd.
(BGNE)
9,780
-51%
10,180
$325.53
$3,313,927.00
SELL
1 Jul 2021
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
4,548
-51%
4,848
$348.15
$1,687,852.40
SELL
1 Jul 2021
Wang Julia Aijun
Chief Financial Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
308
$349.06
$107,511.68
SELL
28 Jun 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,200
-61%
1,925
$354.97
$683,323.00
SELL
28 Jun 2021
Wang Lai
Global Head of R&D, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
455
$362.48
$164,929.95
SELL
28 Jun 2021
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
446
$365.00
$162,790.00
SELL
18 Jun 2021
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
486
$325.89
$158,383.47
SELL
16 Jun 2021
Wu Xiaobin
President, COO & GM China, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,156
$330.93
$382,550.56
SELL
16 Jun 2021
Wang Lai
Global Head of R&D, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
802
$331.15
$265,583.20
SELL
16 Jun 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
469
$325.66
$152,733.03
SELL
9 Jun 2021
Chen Timothy Yung-Cheng
Director
BeiGene, Ltd.
(BGNE)
2,152
-73%
6,000
$351.67
$2,110,017.80
SELL
7 Jun 2021
Wu Xiaobin
President, COO & GM China, Officer
BeiGene, Ltd.
(BGNE)
573
-85%
3,398
$352.54
$1,197,917.10
SELL
7 Jun 2021
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
650
$354.16
$230,202.52
SELL
7 Jun 2021
Wang Lai
Global Head of R&D, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
656
$354.26
$232,392.33
SELL
7 Jun 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
603
$351.55
$211,985.56
SELL
28 May 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
2,040
$357.98
$730,280.80
SELL
10 May 2021
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
2,294
-59%
3,394
$300.46
$1,019,751.80
SELL
3 May 2021
Wu Xiaobin
President, COO & GM China, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
6,715
$343.00
$2,303,245.00
SELL
29 Apr 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,400
-51%
1,500
$354.92
$532,387.00
SELL
29 Mar 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,200
-55%
1,500
$324.00
$485,992.56
SELL
26 Feb 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,400
-51%
1,500
$320.73
$481,099.00
SELL
29 Jan 2021
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,200
-55%
1,500
$322.99
$484,492.16
SELL
14 Jan 2021
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
5,606
-71%
14,000
$344.85
$4,827,945.00
SELL
4 Jan 2021
BAKER BROS. ADVISORS LP
Director, 10% Owner
BeiGene, Ltd.
(BGNE)
968,943
-11%
121,154
$220.50
$26,714,458.00
SELL
29 Dec 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,300
-53%
1,500
$249.13
$373,690.03
SELL
14 Dec 2020
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
87,800
-51%
91,900
$229.04
$21,048,456.00
SELL
4 Dec 2020
BAKER BROS. ADVISORS LP
Director, 10% Owner
BeiGene, Ltd.
(BGNE)
979,003
-60%
1,511,546
$220.50
$333,295,900.00
SELL
30 Nov 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,396
-51%
1,500
$267.82
$401,722.53
BUY
13 Nov 2020
Greg Gianforte
Congressman (House)
BeiGene, Ltd.
(BGNE)
N/A
N/A
N/A
$1,001 - $15,000
SELL
29 Oct 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
239
-86%
1,500
$300.06
$450,093.00
SELL
16 Oct 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
0
-100%
5,000
$320.00
$1,600,000.00
SELL
5 Oct 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
0
-100%
5,000
$300.00
$1,500,000.00
SELL
5 Oct 2020
Wu Xiaobin
President & GM China, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
4,000
$300.00
$1,200,000.00
SELL
5 Oct 2020
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
13,183
-51%
14,000
$299.60
$4,194,413.50
SELL
29 Sep 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,300
-53%
1,500
$280.38
$420,568.28
SELL
28 Sep 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
22,853
-70%
54,303
$280.39
$15,226,092.00
SELL
25 Sep 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
620
-88%
5,000
$280.42
$1,402,116.20
SELL
25 Sep 2020
Wu Xiaobin
President & GM China, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
4,000
$280.35
$1,121,406.00
SELL
17 Sep 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
84
-98%
5,000
$260.27
$1,301,355.90
SELL
17 Sep 2020
Wu Xiaobin
President & GM China, Officer
BeiGene, Ltd.
(BGNE)
500
-88%
4,000
$260.33
$1,041,326.90
SELL
14 Sep 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
16,963
-82%
81,228
$253.46
$20,587,970.00
SELL
14 Sep 2020
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
13,600
-50%
14,000
$250.27
$3,503,763.50
SELL
3 Sep 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
2,128
-59%
3,128
$233.07
$729,045.06
SELL
31 Aug 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
26,607
-69%
61,042
$233.21
$14,235,596.00
SELL
28 Aug 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
2,200
-57%
3,000
$242.21
$726,626.30
SELL
19 Aug 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
37,685
-70%
92,177
$237.06
$21,851,790.00
SELL
12 Aug 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
6,407
-87%
42,968
$212.71
$9,139,562.00
SELL
10 Aug 2020
Chen Timothy Yung-Cheng
Director
BeiGene, Ltd.
(BGNE)
0
-100%
7,000
$212.92
$1,490,459.60
SELL
10 Aug 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
2,500
-61%
4,000
$211.06
$844,229.30
SELL
5 Aug 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
16,554
-51%
17,254
$223.27
$3,852,273.20
SELL
3 Aug 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
15,100
-72%
40,559
$221.27
$8,974,527.00
SELL
29 Jul 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,699
-63%
3,000
$209.93
$629,787.00
SELL
22 Jul 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
21,612
-56%
27,748
$238.34
$6,613,503.00
SELL
20 Jul 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
22,003
-71%
55,175
$251.84
$13,895,479.00
SELL
20 Jul 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
4,700
-78%
17,000
$251.51
$4,275,636.50
SELL
17 Jul 2020
Wu Xiaobin
President & GM China, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
3,300
$249.22
$822,422.40
SELL
13 Jul 2020
Wu Xiaobin
President & GM China, Officer
BeiGene, Ltd.
(BGNE)
700
-89%
5,700
$230.00
$1,310,997.60
SELL
7 Jul 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
0
-100%
6,000
$200.00
$1,200,000.00
SELL
7 Jul 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
3,921
$200.00
$784,200.00
SELL
6 Jul 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
16,929
-76%
53,914
$199.12
$10,735,455.00
SELL
1 Jul 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
4,157
-53%
4,847
$190.75
$924,571.90
SELL
29 Jun 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
1,800
-74%
5,251
$191.85
$1,007,390.70
SELL
29 Jun 2020
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
300
$191.23
$57,368.01
SELL
26 Jun 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
4,014
$195.73
$785,647.10
SELL
22 Jun 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
9,640
-80%
39,732
$185.90
$7,385,982.50
SELL
22 Jun 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
4,155
-72%
11,000
$184.09
$2,024,971.00
SELL
10 Jun 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
900
$175.07
$157,563.00
SELL
8 Jun 2020
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
453
$170.84
$77,390.52
SELL
8 Jun 2020
Wu Xiaobin
President & GM China, Officer
BeiGene, Ltd.
(BGNE)
1,600
-63%
2,800
$170.83
$478,317.50
SELL
8 Jun 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
631
$170.84
$107,800.04
SELL
8 Jun 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
2,500
-70%
6,000
$170.91
$1,025,454.60
SELL
29 May 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,000
-60%
1,500
$163.86
$245,783.53
SELL
19 May 2020
Glazer Donald W.
Director
BeiGene, Ltd.
(BGNE)
0
-100%
10,000
$169.84
$1,698,400.00
SELL
1 May 2020
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
3,635
-56%
4,635
$141.43
$655,537.40
SELL
1 May 2020
Wu Xiaobin
President & GM China, Officer
BeiGene, Ltd.
(BGNE)
1,769
-79%
7,024
$141.33
$992,711.00
SELL
29 Apr 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,500
$162.30
$243,450.00
SELL
16 Apr 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,500
$160.00
$240,000.00
SELL
4 Mar 2020
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
1,969
-71%
5,000
$157.14
$785,681.25
SELL
18 Feb 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
321
-82%
1,500
$170.25
$255,379.98
SELL
21 Jan 2020
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
687
-68%
1,500
$170.69
$256,042.48
SELL
17 Dec 2019
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
55,204
-53%
62,259
$160.62
$10,000,101.00
SELL
16 Dec 2019
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,400
-51%
1,500
$165.14
$247,710.36
SELL
18 Nov 2019
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
23,844
-51%
25,000
$194.34
$4,858,616.00
SELL
18 Nov 2019
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,300
-53%
1,500
$194.49
$291,740.25
SELL
15 Nov 2019
Wu Xiaobin
President & GM China, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,000
$202.05
$202,050.00
SELL
13 Nov 2019
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
0
-100%
13,000
$194.63
$2,530,198.20
SELL
4 Nov 2019
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
28,331
-53%
32,900
$190.46
$6,266,007.00
SELL
4 Nov 2019
Chen Timothy Yung-Cheng
Director
BeiGene, Ltd.
(BGNE)
3,800
-67%
8,000
$189.86
$1,518,844.80
SELL
1 Nov 2019
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
0
-100%
2,000
$180.00
$360,000.00
SELL
1 Nov 2019
Wu Xiaobin
President & GM China, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,000
$180.00
$180,000.00
SELL
3 Sep 2019
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
2,944
$144.03
$424,030.28
SELL
23 Aug 2019
Chen Timothy Yung-Cheng
Director
BeiGene, Ltd.
(BGNE)
0
-100%
8,614
$144.96
$1,248,680.00
SELL
12 Aug 2019
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,700
-59%
2,500
$134.74
$336,854.72
SELL
29 Jul 2019
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
7,630
-57%
10,130
$134.54
$1,362,896.50
SELL
8 Jul 2019
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
1,906
-61%
3,106
$126.87
$394,055.47
SELL
1 Jul 2019
Wang Xiaodong
Director, Chair, Scientific Advisory Brd
BeiGene, Ltd.
(BGNE)
2,647
-64%
4,847
$126.46
$612,937.50
SELL
27 Jun 2019
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
3
-99%
430
$124.52
$53,541.94
SELL
27 Jun 2019
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
122,317
-4%
5,876
$9.47
$55,652.77
SELL
28 May 2019
Mikie Sherrill
Congressman (House)
BeiGene, Ltd.
(BGNE)
N/A
N/A
N/A
$1,001 - $15,000
SELL
21 May 2019
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
23,200
$130.21
$3,020,860.50
SELL
20 May 2019
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
2,500
$130.07
$325,167.56
SELL
13 May 2019
Glazer Donald W.
Director
BeiGene, Ltd.
(BGNE)
0
-100%
15,027
$125.11
$1,880,028.00
SELL
6 May 2019
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,800
$130.01
$234,014.03
SELL
1 May 2019
Wu Xiaobin
President & GM China, Officer
BeiGene, Ltd.
(BGNE)
23,135
-20%
5,955
$124.52
$741,545.60
SELL
1 May 2019
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
1,422
-66%
2,824
$125.18
$353,504.53
SELL
8 Apr 2019
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
13,330
-51%
14,130
$142.77
$2,017,314.50
SELL
14 Mar 2019
Glazer Donald W.
Director
BeiGene, Ltd.
(BGNE)
0
-100%
14,973
$136.10
$2,037,825.40
SELL
7 Mar 2019
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
2,636
$130.28
$343,425.56
SELL
4 Mar 2019
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
100
-99%
25,499
$151.73
$3,868,938.50
SELL
1 Mar 2019
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
2,700
-64%
5,000
$146.83
$734,125.00
SELL
17 Dec 2018
Peterson Amy C.
CMO, Immuno-oncology, Officer
BeiGene, Ltd.
(BGNE)
8,510
-70%
20,000
$133.68
$2,673,536.00
SELL
10 Dec 2018
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
3,738
-52%
4,138
$135.78
$561,862.94
SELL
3 Dec 2018
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
2,329
-68%
5,000
$152.41
$762,060.90
SELL
26 Nov 2018
OYLER JOHN
Chief Executive Officer, Director, Officer
BeiGene, Ltd.
(BGNE)
12,503
-70%
29,195
$143.66
$4,194,035.50
SELL
26 Nov 2018
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
3,000
$139.58
$418,750.22
SELL
19 Nov 2018
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
3,900
-56%
5,000
$124.30
$621,489.90
SELL
8 Nov 2018
Peterson Amy C.
CMO, Immuno-oncology, Officer
BeiGene, Ltd.
(BGNE)
9,109
-81%
40,000
$120.20
$4,808,089.00
SELL
4 Sep 2018
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
2,911
$174.60
$508,246.94
SELL
29 Aug 2018
Glazer Donald W.
Director
BeiGene, Ltd.
(BGNE)
13,384
-13%
2,000
$179.00
$358,000.00
SELL
23 Aug 2018
Peterson Amy C.
CMO, Immuno-oncology, Officer
BeiGene, Ltd.
(BGNE)
4,661
-55%
5,769
$169.12
$975,666.44
SELL
13 Aug 2018
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
1,249
-73%
3,449
$158.77
$547,590.75
BUY
2 Aug 2018
BAKER BROS. ADVISORS LP
Director, 10% Owner
BeiGene, Ltd.
(BGNE)
600,791
+111%
5,814,100
$108.00
$627,922,800.00
SELL
16 Jul 2018
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
0
-100%
2,550
$164.12
$418,497.30
SELL
16 Mar 2018
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
28,628
-58%
40,000
$160.27
$6,410,650.50
SELL
28 Feb 2018
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
24,062
-80%
99,000
$145.63
$14,416,931.00
SELL
28 Feb 2018
Li Ji
EVP and Gl. Head of Bus. Dev., Officer
BeiGene, Ltd.
(BGNE)
8,251
-54%
10,000
$146.88
$1,468,759.80
BUY
18 Jan 2018
BAKER BROS. ADVISORS LP
Director, 10% Owner
BeiGene, Ltd.
(BGNE)
708,025
+155%
1,980,198
$101.00
$200,000,000.00
SELL
26 Dec 2017
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
110,179
-15%
20,137
$96.46
$1,942,514.80
SELL
21 Dec 2017
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,000
$98.00
$98,000.00
SELL
13 Dec 2017
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
200
-88%
1,500
$94.25
$141,380.81
SELL
6 Dec 2017
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
161,145
-47%
144,000
$93.95
$13,529,287.00
SELL
4 Dec 2017
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
0
-100%
1,100
$86.00
$94,600.00
SELL
27 Nov 2017
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
263,137
-24%
85,906
$84.66
$7,272,904.00
SELL
16 Nov 2017
Huang Jane
CMO, Hematology, Officer
BeiGene, Ltd.
(BGNE)
1,100
-59%
1,600
$86.25
$138,000.00
SELL
13 Nov 2017
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
411,313
-26%
150,957
$80.50
$12,152,374.00
SELL
13 Nov 2017
Peterson Amy C.
CMO, Immuno-oncology, Officer
BeiGene, Ltd.
(BGNE)
1,201
-74%
3,601
$82.96
$298,747.10
BUY
11 Aug 2017
BAKER BROS. ADVISORS LP
Director, 10% Owner
BeiGene, Ltd.
(BGNE)
372,975
+89%
176,056
$71.00
$12,499,976.00
SELL
12 Jul 2017
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
16,300
-55%
20,000
$72.44
$1,448,704.40
SELL
10 Jul 2017
Glazer Donald W.
Director
BeiGene, Ltd.
(BGNE)
7,206
-60%
10,810
$72.15
$779,899.60
SELL
6 Jul 2017
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
212,055
-50%
219,400
$64.82
$14,221,124.00
SELL
28 Jun 2017
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
26,600
-56%
35,000
$44.95
$1,573,345.40
SELL
22 Jun 2017
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
62,321
-61%
98,500
$44.16
$4,349,621.50
SELL
2 Jun 2017
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
55,000
-9%
5,539
$40.00
$221,560.00
SELL
3 May 2017
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
60,539
-19%
14,461
$40.80
$590,042.10
SELL
27 Apr 2017
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
145,340
-19%
36,149
$40.47
$1,462,808.00
SELL
5 Apr 2017
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
81,194
-12%
11,650
$36.83
$429,085.00
SELL
22 Mar 2017
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
86,850
-30%
38,107
$36.96
$1,408,612.40
SELL
16 Mar 2017
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
181,489
-14%
31,989
$39.39
$1,260,073.00
SELL
8 Mar 2017
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
124,757
-22%
36,892
$39.89
$1,471,756.50
SELL
2 Mar 2017
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
217,708
-33%
108,999
$40.91
$4,459,330.00
SELL
23 Feb 2017
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
161,649
-19%
38,351
$38.19
$1,464,792.90
SELL
16 Feb 2017
OYLER JOHN
Chief Executive Officer, Director, Officer, 10% Owner
BeiGene, Ltd.
(BGNE)
325,410
-16%
64,963
$40.55
$2,634,010.80
SELL
23 Nov 2016
Wang Xiaodong
Director
BeiGene, Ltd.
(BGNE)
0
-100%
93,750
$32.00
$3,000,000.00
BUY
23 Nov 2016
Malley Thomas
Director
BeiGene, Ltd.
(BGNE)
30,000
+100%
30,000
$32.00
$960,000.00
BUY
18 Nov 2016
BAKER BROS. ADVISORS LP
Director, 10% Owner
BeiGene, Ltd.
(BGNE)
355,198
+125%
1,760,495
$32.00
$56,335,840.00
SELL
28 Sep 2016
Glazer Donald W.
Director
BeiGene, Ltd.
(BGNE)
11,300
-78%
41,463
$30.66
$1,271,174.50
SELL
26 Sep 2016
Glazer Donald W.
Director
BeiGene, Ltd.
(BGNE)
41,463
-53%
47,149
$29.61
$1,395,991.50
SELL
22 Sep 2016
Glazer Donald W.
Director
BeiGene, Ltd.
(BGNE)
88,612
-29%
36,443
$31.02
$1,130,354.60
SELL
19 Sep 2016
Glazer Donald W.
Director
BeiGene, Ltd.
(BGNE)
125,055
-34%
67,252
$31.42
$2,113,061.00
BUY
8 Feb 2016
BAKER BROS. ADVISORS LP
Director, 10% Owner
BeiGene, Ltd.
(BGNE)
189,374
+110%
1,912,680
$24.00
$45,904,320.00
BUY
8 Feb 2016
Liang Howard
CFO & Chief Strategy Officer, Officer
BeiGene, Ltd.
(BGNE)
65,000
+100%
65,000
$1.85
$120,250.00
BUY
8 Feb 2016
Yuan RuiRong
Chief Medical Officer, Officer
BeiGene, Ltd.
(BGNE)
130,000
+100%
130,000
$1.85
$240,500.00
Home